Literature DB >> 8236333

Apathy following cerebrovascular lesions.

S E Starkstein1, J P Fedoroff, T R Price, R Leiguarda, R G Robinson.   

Abstract

BACKGROUND AND
PURPOSE: Although apathy has been reported to constitute a frequent sequela of stroke lesions, there have been no prospective studies on the frequency and correlates of apathy after stroke lesions. In the present study, we examined the frequency and correlates of apathy in a consecutive series of 80 patients with cerebrovascular lesions.
METHODS: We included patients within the first 10 days after a stroke lesion. Patients were examined with a comprehensive neuropsychiatric battery that included the Apathy Scale.
RESULTS: Eighteen patients (22.5%) showed apathy, nine of whom were also depressed. On the other hand, 18 patients (22.5%) showed depression in the absence of apathy. Although depression and apathy may exist independent of one another, major depression (but not minor depression) was associated with an increased frequency of apathy. Apathy was also significantly associated with older age, cognitive impairments, and deficits in activities of daily living. Finally, apathy was significantly associated with lesions in the posterior limb of the internal capsule.
CONCLUSIONS: These findings demonstrate that apathy is a frequent finding among patients with acute stroke lesions and may coexist with important emotional and cognitive poststroke disturbances.

Entities:  

Mesh:

Year:  1993        PMID: 8236333     DOI: 10.1161/01.str.24.11.1625

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  65 in total

Review 1.  Apathy in neurologic disorders.

Authors:  J Duffy
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

2.  Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease.

Authors:  S E Starkstein; L Sabe; S Vázquez; G Di Lorenzo; A Martínez; G Petracca; A Tesón; E Chemerinski; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

Review 3.  What is the role of brain mechanisms underlying arousal in recovery of motor function after structural brain injuries?

Authors:  Andrew M Goldfine; Nicholas D Schiff
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

Review 4.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

Review 5.  Developments in treating the nonmotor symptoms of stroke.

Authors:  Argye E Hillis
Journal:  Expert Rev Neurother       Date:  2020-05-12       Impact factor: 4.618

6.  Brain microstructure of subclinical apathy phenomenology in healthy individuals.

Authors:  Gianfranco Spalletta; Sabrina Fagioli; Carlo Caltagirone; Fabrizio Piras
Journal:  Hum Brain Mapp       Date:  2012-07-17       Impact factor: 5.038

7.  Post-stroke apathy and hypersomnia lead to worse outcomes from acute rehabilitation.

Authors:  Ari L Harris; Jessica Elder; Nicholas D Schiff; Jonathan D Victor; Andrew M Goldfine
Journal:  Transl Stroke Res       Date:  2013-10-19       Impact factor: 6.829

8.  Bilateral pallidotomy for treatment of Parkinson's disease induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation.

Authors:  M Merello; S Starkstein; M I Nouzeilles; G Kuzis; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

9.  An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients.

Authors:  Ellen M Whyte; Eric J Lenze; Meryl Butters; Elizabeth Skidmore; Kris Koenig; Mary Amanda Dew; Louis Penrod; Benoit H Mulsant; Bruce G Pollock; Leonard Cabacungan; Charles F Reynolds; Michael C Munin
Journal:  Cerebrovasc Dis       Date:  2008-07-31       Impact factor: 2.762

Review 10.  Treatment of stroke in older patients. A state of the art review.

Authors:  G Harper
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.